Methylphenidate Treatment Response Study of Genetic Polymorphism in Attention Deficit Hyperactivity Disorder(ADHD)

Seoul National University

Status and phase: Unknown; Phase 4

Conditions: Attention Deficit Hyperactivity Disorder

Treatments: Drug: Methylphenidate

Study type: Interventional

Funder types: Other

Identifiers

NCT00862108

A080054

Details and patient eligibility

About

The purpose of this study is to determine whether norepinephrine gene polymorphism affect to treatment response in ADHD

Enrollment: 50 estimated patients

Sex: All

Ages: 6 to 18 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• diagnosis made by DSM-IV and K-SADS-PL
• IQ > 71

Exclusion criteria

• genetic disorder
• history of acquired brain injury
• seizure disorder
• other neurologic disorder
• mental disorder, pervasive developmental disorder
• obsessive-Compulsive disorder
• communication disorder
• learning disorder

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

50 participants in 1 patient group

Methylphenidate

Experimental group

Treatment:

Drug: Methylphenidate